Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-019792

Director sold 23,333 shares at $16.86 ($393,394)

  • Director acquired 23,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hutson Nancy J · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-10 Exercise or conversion : show line 1 in the form +8,333 $2.85 $23,749 73,406 D
2021-06-10 Exercise or conversion : show line 2 in the form +15,000 $3.32 $49,800 88,406 D
2021-06-10 Sale : show line 3 in the form −23,333 $16.86 $393,394 65,073 D
Open-market sales · 23,333 sh · avg $16.86 · $393,394

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-06-10 Exercise or conversion : show line 4 in the form Non-Qualified Stock Option −8,333 0 D
2021-06-10 Exercise or conversion : show line 5 in the form Automatic Stock Option Grant −15,000 0 D
Loading xslF345X03/form4.xml…